Adam Glen & Jack Reid Founders Unicorn Biotechnologies In this interview, News-Medical speaks to Adam Glen and Jack Reid, founders of Unicorn Biotechnologies, about how their benchtop system Emmet is ...

Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of the soluble protein CCL24 in ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry ... the University itself faded into the background. Harvard’s Return But, ever so slowly ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower, while warning the sector is “dangerously close to falling behind ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

The layoffs are scheduled for May 28. — Nkarta, a biotech company, 53 job cuts in South San Francisco. The downsizing occurred on March 31. The job cuts were all described as permanent ...